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UremiaAbstract Several studies have demonstrated that uremic patients who have preserved left ventric-
ular (LV) systolic function could still have subtle systolic dysfunction. In our study, we assessed the
right ventricular (RV) and LV myocardial functions measured by conventional echocardiography
and two-dimensional (2D) longitudinal speckle-tracking in hemodialysis and non-dialysis recently
diagnosed uremic patients. The study population consisted of 24 newly diagnosed uremic patients,
25 hemodialysis patients, and 20 healthy controls. The RV and LV longitudinal strains were signif-
icantly lower in patients than in controls (9.6 vs. 15.3, P< 0.001 for RV and 11.3 vs. 14.8,
p< 0.001 for LV). In the hemodialysis group, the RV longitudinal strain was significantly lower
than in the non-dialysis group (p= 0.018). The RV longitudinal strain was correlated with hyper-
tension and LV strain. The 2-D longitudinal speckle tracking can detect early ventricular (left and
right) systolic dysfunction in patients with uremia in the presence of normal systolic function by
conventional methods.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In dialysis patients, both cardiovascular and non-
cardiovascular mortality are significantly increased when
compared to the general population [9]. In particular, cardio-
vascular mortality contributes to about 40% of all-cause mor-
tality in these patients, mainly due to sudden cardiac death
[11]. Several parameters, such as left ventricular hypertrophy
(LVH) and left ventricular (LV) systolic dysfunction, have
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outcome in dialysis patients. Diastolic heart dysfunction, as
assessed by tissue Doppler imaging (TDI), has also demon-
strated significant incremental prognostic value for all-cause
mortality and cardiovascular death [26].
Most studies have used the conventional echocardio-
graphic parameters, such as ejection fraction and fraction
shortening, of cardiac function that are usually normal in
uremic patients [11,26]. However, a previous study showed
that these conventional echocardiographic parameters do
not sufficiently describe the regional systolic function and
the loading conditions that affect these parameters [22].
Recently, studies have mainly focused on the use of Doppler
tissue imaging in assessing LV regional systolic function by
measuring tissue velocities, displacement, strain, and strain
rate. Myocardial systolic excursion velocity (S0) is a well-
established, easy and reproducible method for the assessment
of right ventricular (RV) systolic global function [21]. It is
considered as one of the most reliable and reproducible meth-
ods for RV systolic function assessment, and it correlates well
with RV ejection fraction (RVEF) as calculated by cardiac
magnetic resonance [13].
Two-dimensional (2D) speckle-tracking echocardiography
(STE) imaging is a relatively novel echocardiographic
approach for assessing regional LV function [2,14]. The analy-
sis of STE imaging can determine deformation and subtract
the effect of tethering and translational motion of the whole
heart. It is, therefore, considered to be superior to other
echocardiographic measures as it can detect the early changes
in myocardial function. Moreover, it enables the assessment
and analyses of strain and strain rate in different myocardial
axes (i.e., longitudinal, circumferential, and radial) due to its
non-dependency on the Doppler angle, as in the case of tissue
Doppler imaging [3,5,8,23].
Therefore, a 2D STE was adopted to detect the subtle
impairment of the LV systolic function in uremic patients
who have a normal LV ejection fraction (LVEF) [12,16].
In our study, we assessed the difference between the RV
and LV myocardial function measured by conventional
echocardiography in hemodialysis and non-dialysis recently
diagnosed uremic patients using 2D longitudinal STE.2. Methodology
2.1. Study patients
Forty-nine uremic patients with an LVEF of 55% or greater
from the nephrology clinic between December 2014 and June
2015 were consecutively enrolled in our study. The exclusion
criteria were patients with arrhythmias, severe valvular heart
disease, uncontrolled hypertension (blood pressure
>140 mmHg and/or diastolic blood pressure >90 mmHg at
the time of examination), a history of acute coronary syn-
drome, liver disease, and those with inadequate 2D STE image
quality. The patients were divided into two groups: group I
included 24 patients who were hospitalized for investigation
of their symptoms of uremia, and group II included 25 patients
on maintenance hemodialysis (the hemodialysis group; 4-h ses-
sions, 3 times weekly for 6 months or more). We recruited 20age and sex-matched control volunteers who had normal
blood pressure and were non-diabetic with normal results on
electrocardiography and transthoracic echocardiography.
The biochemical indexes of all the study participants were eval-
uated at the hospital laboratory. Written and informed con-
sent was obtained from all the study participants. The study
was approved by the local ethics committee of the Assiut
University Hospital.
2.2. Echocardiography
All the echocardiographic studies were done using a commer-
cial scanner (iE33; Philips Medical System, USA). Real-time
2D echocardiographic imaging was performed from the car-
diac apex by an S4 transducer. The full-volume acquisition
was recorded with five consecutive cardiac cycles during a
single breath-hold. Then, off-line analysis of recorded images
was done using CMQ Q-Lab 9 (Philips Medical System,
USA). An experienced echocardiographer obtained all the
images using the standard protocol, and another researcher
who was blinded to the clinical data of the study subjects
analyzed the data. The LV diameters were measured at the
end-systole and end-diastole phases. The peak systolic S0
wave, the early (E0) and late (A0) diastolic peak velocities of
the septal and lateral mitral annuli, as well as lateral tricuspid
annulus, were measured by pulse wave Doppler and Doppler
tissue imaging. S0 was obtained using the A4C view, and the
measurement was performed at the lateral tricuspid annulus
using color Doppler Tissue Imaging (DTI). Subsequently,
the E0/A0 ratio was calculated to evaluate the LV and RV
diastolic function. The RV systolic function was assessed
using Fractional Area Change (FAC) by measuring the dif-
ference between RV volume in diastole and systole in A4C
view. The pulmonary artery systolic pressure was measured
using tricuspid regurge velocity gradient, and the RA pres-
sure was estimated using inferior vena cava (IVC) diameter
and distensibility [10].
2.2.1. Assessment of global ventricular longitudinal strain
The global longitudinal systolic strain was assessed via the
automated functional imaging method. Three apical views
were recorded in each patient (apical long-axis and four- and
two-chamber views) in grayscale with a frame rate of at least
50 per second. The mitral annulus and the LV apex were
defined in each view. Using modified apical 4-chamber view,
RV was traced to obtain RV global longitudinal systolic strain.
The strain analyses were done on an offline basis (Fig. 1). The
echocardiographic data were gathered and interpreted blindly
to the subjects’ clinical status.
2.3. Statistical analysis
SPSS version 21 was used for statistical analysis. Continuous
variables were expressed as mean ± SD. Unpaired t-test was
used to compare between patients and controls and between
the two renal groups. Chi-square test was used when appropri-
ate. Pearson’s bivariate correlation test was used to correlate
between the different Doppler parameters and both RVS and
LVS.
Figure 1 Shows screen shot of Q-lab 9 software, with tracing of RV in modifies 4-chamber view.
Table 2 Echocardiographic differences between patients and
control, data presented as mean ± SD, EF = Ejection Frac-
tion, EDD= End-diastolic diameter, FAC= Fractional Area
Change, IVS = Interventricular Septum, PASP = Pulmonary
Artery systolic Pressure, PWT= Posterior Wall Thickness,
RVID = Right Ventricular Diameter.
Patients Control p-value
EF 0.62 ± 0.08 0.63 ± 0.05 0.650
EDD 5.16 ± 0.81 3.9 ± 0.73 <0.001
IVS 1.1 ± 0.29 0.8 ± 0.16 0.006
PWT 1.0 ± 0.22 0.8 ± 0.12 0.002
RVID 1.90 ± 0.46 1.88 ± 0.31 0.126
FAC 34.67 ± 2.5 36.89 ± 2.67 0.089
PASP 34.7 ± 9.7 24.5 ± 5.5 0.004
Table 3 Tissue Doppler parameters in patients and control,
data presented as mean ± SD. S; systolic, LAS; lateral mitral
annular systolic velocity.
Patients Control P-value
Medial S 7.81 ± 1.9 9 ± 1.74 0.89
Medial E0 wave 6.8 ± 2.7 12.4 ± 3.3 <0.001
Medial A0 8.38 ± 2.2 7.79 ± 1.7 0.390
Medial E0/A0 0.85 ± 0.38 1.7 ± 0.71 <0.001
LAS 8.1 ± 2 8 ± 1.9 0.879
Lateral E0 wave 7.6 ± 3.15 11.1 ± 3.38 0.004
Lateral A0 9 ± 2.9 8.2 ± 3 0.410
2-D Speckle tracking for assessing regional LV function in hemodialysis 1413. Results
3.1. Patients versus control
The demographics (or characteristics) of the patients and con-
trols are provided in Table 1 Uremic patients showed signifi-
cantly increased LV wall thickness as well as larger LV
dimensions, but there was no significant difference in RV
dimensions, LV fractional shortening or ejection fraction
between the groups, as shown in Table 2. The pulmonary
artery systolic pressure was significantly higher in the patients
compared to the controls.
Annular systolic S0 velocities were similar in patients com-
pared to controls while annular early diastolic E0 velocities
were much lower in uremic patients when compared to healthy
controls, as shown in Table 3. Longitudinal RV and LV strains
were significantly lower in patients than in controls (RVS:
9.6 vs. 15.8, p< 0.001; LVS: 11.3 vs. 14.8, p< 0.001).
3.2. Correlations of RV and LV strains
Both RV and LV longitudinal strains were not affected by age
(r= 0.226, p= 0.559), sex, level of serum creatinine
(r= 0.198, p= 0.269), or the presence of diabetes. How-
ever, both the strains were significantly decreased due to the
presence of hypertension (Tables 4A).
Meanwhile, both RV and LV strains were significantly
decreased in parallel with the impaired diastolic parametersTable 1 Patients and control demographics.
Patients Control p-value
Number 49 20
Sex Male/Female (32/17) 65% (12/8) 60% 0.749
Age 42.9 ± 15.13 35.2 ± 11.15 0.140
Lateral E0/A0 1.47 ± 0.62 0.89 ± 0.45 0.002
Tricuspid S 12.6 ± 2.9 12.4 ± 2.3 0.880
Tricuspid E0 9.6 ± 3.9 13.1 ± 6.1 0.028
Tricuspid A0 13.3 ± 5.6 12.7 ± 2.8 0.764
Tricuspid E0/A0 1.1 ± 0.36 0.84 ± 0.56 0.2identified by pulsed wave tissue Doppler recordings
(Table 4B).
Table 4A RVS and LVS variation according to sex and presence of DM or HTN.
HTN DM Sex
Yes No P Yes No P Male Female P
RVS 9.6 12.2 0.03 9.9 9.5 0.745 10.2 8.4 0.09
LVS 11 13 0.01 12.1 11.2 0.326 11.6 10.8 0.360
Table 4B Correlation between RVS and different tissue Doppler parameters LVS = left ventricular strain, RVS right ventricular
strain, MAE= mitral annular Ewave, LAE= lateral annular Ewave, TAE = tricuspid annular Ewave.
MAE Medial E0/A0 LAE Lateral E0/A0 TAE Tricuspid E0/A0
R p r P r P r P r P r P
RVS 0.478 0.001 0.471 0.001 0.514 <0.001 0.538 <0.001 0.401 0.005 0.286 0.05
LVS 0.495 0.001 0.518 <0.001 0.363 0.018 0.409 0.003 0.391 0.005 0.378 0.007
Table 7 Diastolic parameters differences between group I
patients with ESRD but no dialysis and group II patients with
ESRD and regular dialysis, data presented as mean ± SD.
Group I Group II p-value
Medial annular E0 wave 7.99 ± 2.9 5.66 ± 1.84 0.002
Medial E0/A0 1.01 ± 0.43 0.7 ± 0.24 0.004
Lateral annular E0 wave 7.64 ± 2.7 7.50 ± 3.58 0.879
Lateral E0/A0 0.91 ± 0.32 0.88 ± 0.57 0.786
Lateral Tricuspid annular E0 10.70 ± 4.4 8.31 ± 2.88 0.036
Tricuspid annular E0/A0 0.91 ± 0.56 0.77 ± 0.56 0.349
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3.3.1. Clinical criteria
Age and sex were comparable between the two groups. Hyper-
tension was more prevalent in group II, and diabetes was more
prevalent in group I; serum creatinine was higher in group II
(p= 0.014), as shown in Table 5.
3.3.2. Echo-Doppler data
Septum and posterior wall were significantly thicker in group
II. There was a trend of lower ejection fraction in group II
patients while RV dimensions and RV systolic pressure were
comparable between the two groups, as shown in Table 6.
Medial mitral annular E0 velocity, E0/A0 ratio, and lateral
tricuspid annular E0 wave velocity were significantly lower in







Sex Male/Female 17/7 70% 15/10 60% 0.695
Age 46.75 ± 17.13 39.16 ± 12.77 0.084
DM 9 37.5% 2 8% 0.003
HTN 15 62.5% 20 80% <0.001
S.Creatinine 8.40 ± 0.26 9.71 ± 1.7 0.001
Table 6 Echocardiographic measurements in group I and
group II, data presented as mean ± SD. EF; Ejection fraction,
EDD; End-diastolic diameter, IVS; Interventricular septum,
PWT; Post wall thickness, RVD; Right ventricular diameter,
PASP; Pulmonary artery systolic pressure.
Group I Group II p-value
EF 0.64 ± 0.09 0.60 ± 0.07 0.096
EDD 5.10 ± 0.88 5.22 ± 0.74 0.612
IVS 0.99 ± 0.18 1.20 ± 0.32 0.007
PWT 0.92 ± 0.12 1.10 ± 0.25 0.004
RVD 1.90 ± 0.46 1.88 ± 0.31 0.825
PASP 36.79 ± 11.1 32.56 ± 7.75 0.1393.4. RV systolic function
There was no significant difference between the two groups in
RV systolic excursion velocity (S0) (Group I vs. group II: 13.2
vs. 11.9, p= 0.443), or FAC (34.67 vs. 35.21, p= 0.098).
3.5. Differences in 2D longitudinal strain
Both longitudinal RV and LV strains were significantly lower
in group II compared to group I (RV strain; 8.55 vs. 10.86,
p= 0.018, LV strain; 10.3 vs. 12.6, p= 0.003).
4. Discussion
Cardiac functions have been insufficiently studied in uremia
patients. To our knowledge, this is the first study that com-
pares the differences in RV myocardial functions in hemodial-
ysis and non-dialysis patients based on 2D STE versus systolic
excursion velocity.
The primary findings of the present study were as follows:
(1) the RV functions detected by 2D STE as well as tissue-
Doppler diastolic velocities were significantly impaired in ure-
mia patients versus healthy control subjects in spite of compa-
rable results using systolic excursion velocity; (2) the global LV
systolic function was normal in the uremic group; however, the
2D derived LV longitudinal strain was more significantly lower
in the hemodialysis group compared to the recently diagnosed
non-dialysis uremic patients; (3) the tissue Doppler annular
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hemodialysis group compared to the non-dialysis group.
These findings can be explained by the following: (1) the
long-standing effect of uremia is well established in hemodial-
ysis patients as compared to the recently diagnosed group I
patients who have uremia for a short period; (2) in most
patients, dialysis does not usually correct the metabolic profile
like hyperphosphatemia, which is toxic to the myocardium
[15]; (3) hypertension is more prevalent in the hemodialysis
group, and RV strain is negatively correlated with
hypertension.
Previous trials that studied RV function in patients with
end-stage renal disease (ESRD) were dependent on the usual
echocardiographic methods such as tricuspid annular plane
systolic excursion and right index of myocardial performance.
These studies found that the RV function deteriorates with
long-standing dialysis [1,7,19].
Other studies have investigated LV systolic and diastolic
dysfunction in patients with chronic renal failure treated with
hemodialysis. These studies have reported that both hyper-
parathyroidism and malnutrition are important factors influ-
encing the development of LVH, which plays an important
role the systolic and diastolic dysfunction in hemodialysis
patients [25].
The present study agreed with Shirley et al. (2005), who
studied LV function in patients with chronic kidney disease
evaluated by color tissue Doppler velocity imaging. They con-
cluded that the Doppler velocity imaging provided additional
information on LV function in chronic kidney disease patients.
In patients with advanced renal failure, the Doppler velocity
imaging revealed more accentuated diastolic dysfunction asso-
ciated with increased systolic blood pressure [11].
The present study was concordant with Manish et al.
(2008), who studied the LV dysfunction in the hemodialysis
population and concluded that LV diastolic dysfunction is
highly prevalent in hemodialysis patients and confers a worse
prognosis in this highly co-morbid population [24]. They stated
that the most commonly used measurement technique, 2D
echocardiography, can underestimate LV function, indicating
a problematic interpretation of the literature. The regular use
of modern measurement techniques can allow for more accu-
rate estimates of prevalence.
The present study agreed with Murata et al., who studied
the role of hemodialysis therapy on LV mechanical dyssyn-
chrony in patients with ESRD quantified by speckle tracking
strain imaging. They found that the presence of ESRD was
associated with longitudinal and radial LV dyssynchronies
[18]. In addition, they also found the hemodialysis therapy to
improve radial LV dyssynchrony dramatically, indicating that
only radial LV dyssynchrony is preload dependent.
Our study was concordant with Yan et al., who reported
that the 2D-STE contributes to the early identification of
impaired LV myocardial function in patients with chronic kid-
ney disease. They concluded that 2D speckle tracking may be
used to identify early abnormalities in patients with chronic
kidney disease who have preserved LV ejection [26]. They also
detected that only the LV circumferential and radial strains
(but not the longitudinal strain) appeared to be better in the
hemodialysis group than in the non-dialysis group.
The present study also agreed with Rathod N. et al. who
studied the assessment of cardiac dysfunction by 2Dechocardiography in patients with chronic kidney disease.
They concluded that patients with chronic kidney disease have
a higher prevalence of diastolic and systolic dysfunctions, and
diastolic dysfunction appears to occur earlier than the systolic
dysfunction [20].
The study was also concordant with Jukema et al. who
studied LV diastolic dysfunction in dialysis patients assessed
by novel speckle tracking strain rate analysis. They found that
diastolic dysfunction is highly prevalent among dialysis
patients and might be underestimated using conventional mea-
surements. They also reported that LV mass and pulse wave
velocity were the only determinants of diastolic dysfunction
in these patients [6].
The present study only disagreed with Ran Chen, et al. who
studied the LV myocardial function in hemodialysis and non-
dialysis uremia patients [4]. They found that the three-
dimensional STE may detect myocardial dysfunction in
patients with uremia who have preserved LVEF. They also
concluded that the global three-dimensional strain and the
regional longitudinal strain appear to be superior in hemodial-
ysis patients compared with non-dialysis patients. This can be
easily explained by the difference in the recruitment of their
patients versus our patients. They included both groups of
hemodialysis and non-dialysis groups from patients who have
long-term uremia (more than 5 years) while we recruited
hemodialysis group from long-term uremic patients and the
other non-dialysis group from recently diagnosed patients hav-
ing short-term uremia.
Our study also agreed with Ma et al., who studied the LV
function in uremic patients using speckle tracking imaging.
They concluded that despite normal ejection fraction in the
uremic group, they had well recorded diastolic dysfunction
as detected by STE [17].
5. Study limitations
The study included a relatively small number of patients.
Moreover, the long-term cardiovascular event rates or survival
assessment in the patients on maintenance hemodialysis were
not presented in this study. In addition, patients with low ejec-
tion fraction (EF < 55%) and/or heart failure were excluded
from the study; this limits the extension of our findings to
the general uremic population. A comparison with patients
with renal transplantation may be needed to elucidate the dif-
ference between the different methods of renal replacement
therapy.
6. Conclusion
RV and LV myocardial functions may be impaired in uremic
patients with preserved ejection fraction and systolic excursion
velocity. Finding a lower ventricular function in the dialysis
patients than recently diagnosed non-dialysis ones implies that
hemodialysis does not seem to correct or protect against the
deleterious myocardial effects of uremia; in such cases, another
dialysis modality or transplantation may be better pursued.
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